General Information of Drug (ID: DMNK2UT)

Drug Name
LA-GDF15
Indication
Disease Entry ICD 11 Status REF
Obesity 5B81 Phase 1 [1]
Cross-matching ID
TTD ID
D8G7UL

References

1 Clinical pipeline report, company report or official report of Novo Nordisk